Survey and Follow-up of the Treatment Adherence and Medication Habits of Early Breast Cancer Patients on Adjuvant Hormonal Therapy With the Aromatase Inhibitor Arimidex.
Phase of Trial: Phase IV
Latest Information Update: 15 Nov 2011
At a glance
- Drugs Anastrozole (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- Acronyms ARIADNE
- Sponsors AstraZeneca
- 15 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Feb 2011 Actual initiation date changed from 1 Apr 2010 to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 08 Feb 2011 Planned end date changed from 1 Oct 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.